Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents

Autor Zanaga, L.P., Miotto, N., Mendes, L.C., Stucchi, R.S.B., Vigani, A.G.
Vydáno v Braz J Med Biol Res (2016)

Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center

Autor Zanaga, L.P., Santos, A.G., Ataíde, E.C., Boin, I.F.S.F., Stucchi, R.S.B.
Vydáno v Braz J Med Biol Res (2019)

Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation

Autor Zanaga, L.P., Vigani, A.G., Angerami, R.N., Giorgetti, A., Escanhoela, C.A.F., Ataíde, E.C., Boin, I.F.S.F., Stucchi, R.S.B.
Vydáno v Braz J Med Biol Res (2017)

Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors

Autor Miotto, N., Mendes, L.C., Zanaga, L.P., Goncales, E.S.L., Lazarini, M.S.K., Pedro, M.N., Goncales, F.L., Stucchi, R.S.B., Vigani, A.G.
Vydáno v Braz J Med Biol Res (2016)